The Safety and Efficacy of Different Doses of Bacillus Calmette Guérin in Superficial Bladder Transitional Cell Carcinoma
Author:
Publisher
Elsevier BV
Subject
Urology
Reference30 articles.
1. A combined analysis of European Organization for Research and Treatment of Cancer and Medical Research Council randomized trials for the prophylactic treatment of stage TaT1 bladder cancer;Pawinski;J Urol,1996
2. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long term course of superficial transitional cell carcinoma of the bladder;Lamm;J Urol,1995
3. Long-term results of intravesical therapy for superficial bladder cancer;Lamm;Urol Clin N Am,1992
4. Strategy for improving therapy of superficial bladder cancer;Ratliff;World J Urol,1991
5. Non-antibody immunotherapy of cancer;Chapman;Curr Opin Immunol,1993
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative Analysis of Very Reduced vs Full Dose BCG Treatment for High-Risk Non-Muscle Invasive Bladder Cancer: A Contemporary Experience from Chile;Bladder Cancer;2023-12-13
2. The Impact of Dose Reduction of Bacillus Calmette–Guerin on Oncological Outcomes and Toxicity in Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis;Bladder Cancer;2023-09-25
3. Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis;Immunotherapy;2023-08
4. The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non–muscle-invasive bladder cancer: A network meta-analysis;Urologic Oncology: Seminars and Original Investigations;2023-06
5. Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis;Cancers;2023-03-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3